NCT00509990View on ClinicalTrials.gov

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

September 30, 2007

Conditions
Atopic Dermatitis
Interventions
DRUG

Pimecrolimus

Pimecrolimus cream 1 %

Trial Locations (6)

Unknown

Novartis Investigative Site, México

Novartis Investigative Site, Monterrey

Novartis Investigative Site, Puebla City

Novartis Investigative Site, Aragua

Novartis Investigative Site, Edo, Carabobo

Novartis Investigative Site, Caracas

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY